Offer - Urjas Oil for just ₹ 1
Cefoprox CV 50 Mg Dry Syrup, a prescription drug, is manufactured in various forms such as Syrup. Other than this, Cefoprox CV 50 Mg Dry Syrup has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Cefoprox CV 50 Mg Dry Syrup depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Cefoprox CV 50 Mg Dry Syrup can also lead to other problems, which have been listed below. Usually, these side effects of Cefoprox CV 50 Mg Dry Syrup go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Cefoprox CV 50 Mg Dry Syrup is Mild for pregnant women and Moderate for women who are breastfeeding. It is important to know if Cefoprox CV 50 Mg Dry Syrup has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Cefoprox CV 50 Mg Dry Syrup related warnings section.
Cefoprox CV 50 Mg Dry Syrup is contraindicated in people with pre-existing medical conditions like Jaundice as it can result in adverse effects. Other contraindications of Cefoprox CV 50 Mg Dry Syrup have been discussed in the sections ahead.
Additionally, Cefoprox CV 50 Mg Dry Syrup may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Cefoprox CV 50 Mg Dry Syrup is considered safe while driving, and is addictive.
Cefoprox CV 50 Mg Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 2 - 12 years (Child) |
|
Is the use of Cefoprox CV 50 Mg Dry Syrup safe for pregnant women?
Cefoprox CV has little to no side effects in pregnant women.
Is the use of Cefoprox CV 50 Mg Dry Syrup safe during breastfeeding?
Cefoprox CV can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Cefoprox CV 50 Mg Dry Syrup on the Kidneys?
There can be some harmful effects on your kidneys after taking Cefoprox CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cefoprox CV 50 Mg Dry Syrup on the Liver?
The liver can be affected by Cefoprox CV. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Cefoprox CV only after medical advice.
What is the effect of Cefoprox CV 50 Mg Dry Syrup on the Heart?
Very few cases of side effects of Cefoprox CV on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Cefoprox CV 50 Mg Dry Syrup unless your doctor advises you to do so -
Is this Cefoprox CV 50 Mg Dry Syrup habit forming or addictive?
Forming a habit of Cefoprox CV 50 Mg Dry Syrup has not been reported.
Interaction between Food and Cefoprox CV 50 Mg Dry Syrup
Taking Cefoprox CV 50 Mg Dry Syrup with food does not cause any problems.
Interaction between Alcohol and Cefoprox CV 50 Mg Dry Syrup
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Cefoprox CV 50 Mg Dry Syrup.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
